Are you Dr. Cha?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 42 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
Box 1270 - M1286
San Francisco, CA 94143Phone+1 415-885-7276Fax+1 415-476-0624
Summary
- Dr. Edward Cha, MD is an oncologist in San Francisco, California. He is currently licensed to practice medicine in California and New York. He is affiliated with UCSF Medical Center and is a Clinical Fellow at UCSF School of Medicine.
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2008 - 2010
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2005 - 2008
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2005
Certifications & Licensure
- CA State Medical License 2008 - 2025
- NY State Medical License 2007 - 2009
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma Start of enrollment: 2012 Jun 09
Publications & Presentations
PubMed
- 145 citationsDefining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce.Harriet M. Kluger, Hussein Abdul-Hassan Tawbi, Maria Libera Ascierto, Michaela Bowden, Margaret K. Callahan
Journal for Immunotherapy of Cancer. 2020-03-01 - 170 citationsAtezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patientsRyan J. Sullivan, Omid Hamid, Rene Gonzalez, Jeffrey R. Infante, Manish R. Patel
Nature Medicine. 2019-06-01 - 114 citationsPhase Ib study of atezolizumab combined with cobimetinib in patients with solid tumorsMatthew D. Hellmann, Tae Won Kim, Carrie B. Lee, B.C. Goh, Wilson H. Miller
Annals of Oncology. 2019-07-01